 Sophie Lalande
Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoxia | 10 | 2025 | 1197 | 3.550 |
Why?
| | Erythropoietin | 4 | 2024 | 100 | 2.720 |
Why?
| | Vasodilation | 5 | 2024 | 521 | 1.790 |
Why?
| | Reperfusion Injury | 3 | 2022 | 292 | 1.690 |
Why?
| | Brachial Artery | 3 | 2024 | 208 | 1.520 |
Why?
| | Oxygen | 7 | 2025 | 978 | 1.440 |
Why?
| | Exercise | 12 | 2024 | 2191 | 1.430 |
Why?
| | Ischemic Preconditioning | 2 | 2022 | 47 | 1.360 |
Why?
| | Follicular Phase | 2 | 2021 | 41 | 1.320 |
Why?
| | Exercise Tolerance | 7 | 2021 | 283 | 1.180 |
Why?
| | Endothelium, Vascular | 3 | 2024 | 955 | 1.060 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2025 | 2578 | 1.040 |
Why?
| | Oxygen Consumption | 8 | 2024 | 718 | 1.010 |
Why?
| | Respiratory Mechanics | 2 | 2019 | 74 | 0.870 |
Why?
| | Sympathetic Nervous System | 4 | 2022 | 181 | 0.810 |
Why?
| | Muscle, Skeletal | 8 | 2022 | 1789 | 0.750 |
Why?
| | Hemodynamics | 4 | 2020 | 1115 | 0.730 |
Why?
| | Blood Volume | 3 | 2021 | 65 | 0.720 |
Why?
| | Heart Failure, Systolic | 2 | 2019 | 26 | 0.690 |
Why?
| | Heart Failure | 6 | 2020 | 2324 | 0.680 |
Why?
| | Cardiovascular System | 2 | 2019 | 138 | 0.680 |
Why?
| | Arm | 1 | 2021 | 110 | 0.650 |
Why?
| | Contraceptives, Oral | 1 | 2020 | 37 | 0.630 |
Why?
| | Luteal Phase | 1 | 2020 | 51 | 0.630 |
Why?
| | Exercise Test | 7 | 2024 | 626 | 0.570 |
Why?
| | Pulmonary Circulation | 4 | 2015 | 429 | 0.550 |
Why?
| | Blood Glucose | 2 | 2025 | 2335 | 0.550 |
Why?
| | Blood Pressure | 9 | 2022 | 1778 | 0.540 |
Why?
| | Estradiol | 1 | 2021 | 512 | 0.530 |
Why?
| | Connectin | 1 | 2017 | 42 | 0.520 |
Why?
| | Hand Strength | 3 | 2019 | 144 | 0.520 |
Why?
| | Rest | 4 | 2015 | 124 | 0.520 |
Why?
| | Cardiac Output | 4 | 2016 | 179 | 0.510 |
Why?
| | Baroreflex | 3 | 2022 | 57 | 0.510 |
Why?
| | Insulin Resistance | 1 | 2025 | 1244 | 0.480 |
Why?
| | Insulin | 3 | 2025 | 2510 | 0.470 |
Why?
| | Resistance Training | 3 | 2024 | 186 | 0.470 |
Why?
| | Aging | 3 | 2024 | 1962 | 0.470 |
Why?
| | Reflex | 1 | 2015 | 70 | 0.450 |
Why?
| | Adult | 23 | 2025 | 40665 | 0.430 |
Why?
| | Erythrocytes | 1 | 2020 | 747 | 0.420 |
Why?
| | Heart Rate | 7 | 2024 | 855 | 0.410 |
Why?
| | Glucose Tolerance Test | 2 | 2025 | 360 | 0.410 |
Why?
| | Exhalation | 2 | 2016 | 29 | 0.410 |
Why?
| | Hemoglobins | 3 | 2024 | 386 | 0.400 |
Why?
| | Humans | 42 | 2025 | 145140 | 0.400 |
Why?
| | Lung | 5 | 2020 | 4101 | 0.400 |
Why?
| | Adaptation, Physiological | 3 | 2023 | 560 | 0.390 |
Why?
| | Stroke Volume | 4 | 2016 | 653 | 0.380 |
Why?
| | Female | 28 | 2025 | 78636 | 0.380 |
Why?
| | Inhalation | 2 | 2016 | 29 | 0.380 |
Why?
| | Airway Resistance | 1 | 2012 | 38 | 0.370 |
Why?
| | Young Adult | 12 | 2024 | 14176 | 0.350 |
Why?
| | Pulmonary Ventilation | 2 | 2009 | 82 | 0.350 |
Why?
| | Male | 29 | 2025 | 72664 | 0.350 |
Why?
| | Heart | 2 | 2013 | 626 | 0.340 |
Why?
| | Middle Aged | 17 | 2025 | 36126 | 0.340 |
Why?
| | Pulmonary Gas Exchange | 3 | 2024 | 116 | 0.320 |
Why?
| | Hypertrophy, Left Ventricular | 2 | 2008 | 123 | 0.310 |
Why?
| | Cardiac Rehabilitation | 2 | 2021 | 46 | 0.310 |
Why?
| | Hypergravity | 1 | 2009 | 6 | 0.310 |
Why?
| | Aged | 15 | 2025 | 26096 | 0.310 |
Why?
| | Aerospace Medicine | 1 | 2009 | 32 | 0.300 |
Why?
| | Acetazolamide | 1 | 2009 | 26 | 0.290 |
Why?
| | Anaerobiosis | 1 | 2009 | 65 | 0.290 |
Why?
| | Apnea | 2 | 2021 | 26 | 0.290 |
Why?
| | Metabolic Syndrome | 1 | 2012 | 360 | 0.290 |
Why?
| | Sulfones | 1 | 2009 | 127 | 0.280 |
Why?
| | Pulmonary Diffusing Capacity | 3 | 2020 | 78 | 0.270 |
Why?
| | Physical Exertion | 1 | 2009 | 205 | 0.270 |
Why?
| | Weight Lifting | 1 | 2007 | 31 | 0.260 |
Why?
| | Ventricular Function | 1 | 2007 | 53 | 0.260 |
Why?
| | Work of Breathing | 2 | 2020 | 3 | 0.250 |
Why?
| | Piperazines | 1 | 2009 | 375 | 0.240 |
Why?
| | Leg | 1 | 2008 | 242 | 0.240 |
Why?
| | Nitric Oxide | 2 | 2024 | 892 | 0.230 |
Why?
| | Vascular Resistance | 4 | 2016 | 369 | 0.230 |
Why?
| | Circuit-Based Exercise | 1 | 2024 | 2 | 0.220 |
Why?
| | Ventricular Function, Left | 3 | 2012 | 539 | 0.210 |
Why?
| | Bronchi | 2 | 2020 | 263 | 0.210 |
Why?
| | Regional Blood Flow | 2 | 2024 | 514 | 0.200 |
Why?
| | Nitrates | 1 | 2024 | 93 | 0.200 |
Why?
| | Age Factors | 3 | 2024 | 3338 | 0.200 |
Why?
| | Anaerobic Threshold | 2 | 2021 | 25 | 0.190 |
Why?
| | Case-Control Studies | 6 | 2019 | 3616 | 0.190 |
Why?
| | Erythropoiesis | 1 | 2023 | 57 | 0.190 |
Why?
| | Sex Factors | 2 | 2021 | 2099 | 0.190 |
Why?
| | Military Personnel | 1 | 2009 | 736 | 0.170 |
Why?
| | Echocardiography | 4 | 2012 | 647 | 0.170 |
Why?
| | Coronary Artery Disease | 2 | 2019 | 747 | 0.170 |
Why?
| | High-Intensity Interval Training | 1 | 2021 | 45 | 0.170 |
Why?
| | Recruitment, Neurophysiological | 1 | 2021 | 40 | 0.170 |
Why?
| | Arterial Pressure | 3 | 2022 | 134 | 0.170 |
Why?
| | Hemoglobinometry | 1 | 2020 | 3 | 0.160 |
Why?
| | Diastole | 2 | 2012 | 146 | 0.160 |
Why?
| | Ventilation-Perfusion Ratio | 1 | 2020 | 11 | 0.160 |
Why?
| | Hypertension | 1 | 2008 | 1269 | 0.150 |
Why?
| | Myocardial Ischemia | 1 | 2021 | 285 | 0.150 |
Why?
| | Autonomic Nervous System | 1 | 2019 | 82 | 0.140 |
Why?
| | Virtual Reality | 1 | 2020 | 82 | 0.140 |
Why?
| | Energy Metabolism | 1 | 2024 | 933 | 0.140 |
Why?
| | Posture | 2 | 2011 | 197 | 0.130 |
Why?
| | Dyspnea | 1 | 2020 | 250 | 0.130 |
Why?
| | Pulmonary Artery | 2 | 2015 | 1126 | 0.130 |
Why?
| | Multiple Chronic Conditions | 1 | 2017 | 34 | 0.130 |
Why?
| | General Practitioners | 1 | 2017 | 26 | 0.130 |
Why?
| | Appointments and Schedules | 1 | 2017 | 96 | 0.130 |
Why?
| | Breath Holding | 1 | 2016 | 10 | 0.120 |
Why?
| | Stress, Mechanical | 1 | 2018 | 494 | 0.120 |
Why?
| | Exercise Therapy | 1 | 2021 | 475 | 0.120 |
Why?
| | Endothelial Cells | 1 | 2022 | 873 | 0.120 |
Why?
| | Vasoconstriction | 2 | 2015 | 216 | 0.120 |
Why?
| | Carbon Monoxide | 1 | 2016 | 82 | 0.110 |
Why?
| | Hypocapnia | 1 | 2015 | 8 | 0.110 |
Why?
| | Carotid Artery, Internal | 1 | 2015 | 45 | 0.110 |
Why?
| | Hypercapnia | 1 | 2015 | 53 | 0.110 |
Why?
| | Middle Cerebral Artery | 1 | 2015 | 56 | 0.110 |
Why?
| | Models, Cardiovascular | 1 | 2016 | 195 | 0.110 |
Why?
| | Outpatients | 1 | 2017 | 447 | 0.100 |
Why?
| | Chronic Disease | 1 | 2020 | 1806 | 0.100 |
Why?
| | Heart Ventricles | 1 | 2017 | 754 | 0.090 |
Why?
| | Cerebrovascular Circulation | 1 | 2015 | 289 | 0.090 |
Why?
| | Myocardium | 1 | 2017 | 931 | 0.090 |
Why?
| | Thoracic Cavity | 1 | 2011 | 2 | 0.090 |
Why?
| | Echocardiography, Doppler | 1 | 2012 | 114 | 0.090 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2011 | 48 | 0.090 |
Why?
| | Prognosis | 1 | 2020 | 4310 | 0.080 |
Why?
| | Hypertension, Pulmonary | 2 | 2020 | 1955 | 0.080 |
Why?
| | Ventricular Function, Right | 1 | 2012 | 296 | 0.080 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2009 | 69 | 0.070 |
Why?
| | Visual Fields | 1 | 2009 | 116 | 0.070 |
Why?
| | Sildenafil Citrate | 1 | 2009 | 60 | 0.070 |
Why?
| | Contrast Media | 1 | 2012 | 497 | 0.070 |
Why?
| | Diuretics | 1 | 2009 | 68 | 0.070 |
Why?
| | Neurotransmitter Agents | 1 | 2009 | 83 | 0.070 |
Why?
| | Time Factors | 4 | 2021 | 7107 | 0.070 |
Why?
| | Animals | 3 | 2023 | 37952 | 0.070 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 38 | 0.070 |
Why?
| | Purines | 1 | 2009 | 186 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 3 | 2015 | 3892 | 0.070 |
Why?
| | Calcium Channel Blockers | 1 | 2008 | 166 | 0.060 |
Why?
| | Vasodilator Agents | 1 | 2009 | 330 | 0.060 |
Why?
| | Hospitalization | 1 | 2017 | 2458 | 0.060 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 229 | 0.060 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2008 | 252 | 0.060 |
Why?
| | Femoral Artery | 1 | 2008 | 190 | 0.060 |
Why?
| | Physical Endurance | 1 | 2008 | 276 | 0.060 |
Why?
| | Recovery of Function | 2 | 2021 | 715 | 0.060 |
Why?
| | Action Potentials | 2 | 2021 | 502 | 0.060 |
Why?
| | Pilot Projects | 2 | 2009 | 1889 | 0.060 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 2183 | 0.050 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2008 | 393 | 0.050 |
Why?
| | Running | 1 | 2024 | 230 | 0.040 |
Why?
| | Blood Flow Velocity | 2 | 2015 | 420 | 0.040 |
Why?
| | Bicycling | 1 | 2021 | 117 | 0.040 |
Why?
| | Cardiorespiratory Fitness | 1 | 2021 | 74 | 0.040 |
Why?
| | Norepinephrine | 1 | 2020 | 200 | 0.040 |
Why?
| | Supine Position | 2 | 2011 | 37 | 0.040 |
Why?
| | Respiratory Function Tests | 2 | 2011 | 543 | 0.040 |
Why?
| | Risk Factors | 2 | 2017 | 10857 | 0.040 |
Why?
| | Occupations | 1 | 2017 | 50 | 0.030 |
Why?
| | Efferent Pathways | 1 | 2016 | 19 | 0.030 |
Why?
| | Europe | 1 | 2017 | 416 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 104 | 0.030 |
Why?
| | Africa South of the Sahara | 1 | 2015 | 54 | 0.030 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2015 | 35 | 0.030 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2015 | 7 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2021 | 11741 | 0.030 |
Why?
| | Pressure | 1 | 2016 | 226 | 0.030 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2015 | 40 | 0.030 |
Why?
| | Capillaries | 1 | 2016 | 125 | 0.030 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2015 | 48 | 0.030 |
Why?
| | Linear Models | 1 | 2016 | 844 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2017 | 1109 | 0.020 |
Why?
| | Blood Gas Analysis | 1 | 2011 | 81 | 0.020 |
Why?
| | Spirometry | 1 | 2011 | 233 | 0.020 |
Why?
| | Vital Capacity | 1 | 2011 | 292 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1300 | 0.020 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2007 | 31 | 0.020 |
Why?
| | Mitral Valve | 1 | 2007 | 95 | 0.010 |
Why?
| | Body Height | 1 | 2007 | 201 | 0.010 |
Why?
| | Electrocardiography | 1 | 2007 | 664 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 2115 | 0.010 |
Why?
| | Body Mass Index | 1 | 2007 | 2437 | 0.010 |
Why?
| | Biomarkers | 1 | 2009 | 4282 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2007 | 8318 | 0.010 |
Why?
|
|
Lalande's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|